Forepont Capital Partners

forepont.com

VCMatch tracks Forepont Capital Partners as an investor focused on Biotech, Medtech, and Digital Health companies, Pre-Seed and Seed rounds, and United States and Europe markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed, Series A

Focus Areas

Biotech, Medtech, Digital Health

Geography

United States and Europe

Investment Thesis

Forepont focuses on investing in science-led healthcare companies whose work can materially improve patient outcomes. The firm pairs a charitable research program (funding basic and academic research) with venture investments, deploying capital plus scientific, technical and operational support to accelerate startups—particularly by investing “before the inflection point” so their experience and know‑how can shape value creation.

Is Forepont Capital Partners right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Forepont Capital Partners is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Biotech, Medtech, Digital Health, and Pharma, especially across United States and Europe.

Focus statement

Forepont invests in biotech, medtech and e-health start-ups in the United States and Europe, providing scientific, technological, financial and operational support while prioritizing projects that can change patients' lives.

Value Add

Tight, established partnerships with physicians, researchers, key opinion leaders, academia, hospitals and large pharmaceutical groups that provide privileged sourcing and clinical insight ("Our established healthcare partners give us a direct and privileged access to new opportunities.")
Integrated philanthropy and investment model—Forepont funds basic academic research alongside venture investments to surface new science ("Forepont philanthropy funds basic and academic research that discovers new science.")
Early-stage, pre-inflection focus designed to allow the firm to shape startups operationally and scientifically ("Investing in Bio&Med Tech before the inflection point allows Forepont’s experience, expertise and know-how to have an immediate and unique impact.")
Hands-on scientific leadership on the team (e.g., a Partner, Science with extensive CSO experience) to guide scientific decisions and de-risk programs
Cross-border expertise in U.S. and European regulatory, market and structuring issues enabling local and international support ("Our deep knowledge of American and European regulations, structures and markets allows us to provide an important support at local and international levels.")
Explicit focus on creating a "patient-investor virtuous circle" connecting research, clinical stakeholders and investors